Or they work by radically new mechanisms. They stoke no egos at the big institutions, enhance no resum s. A formidable mechanism has been created to keep such 'disreputable' substances out of the cancer marketplace. Declare them worthless, without a trial. Finally, brand them as dangerous quackery.
Systematized harassment pervades the eld of innovative cancer therapy.
But there is another, more compelling, reason to do so. That is the fundamental question of human rights. Patient autonomy is an essential part of democracy. Since 1963, FDA has demanded a preponderance of medical opinion before allowing a new drug to be marketed. This can take decades and millions of dollars.